Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from BioHarvest Sciences ( (BHST) ).
BioHarvest Sciences Inc. has released its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2025. The financial report highlights a significant increase in cash and cash equivalents from $2,390,000 at the end of 2024 to $10,966,000 as of September 30, 2025, indicating improved liquidity. This financial performance reflects the company’s ongoing efforts to strengthen its financial position, which could enhance its competitive edge in the biotechnology sector.
The most recent analyst rating on (BHST) stock is a Hold with a $7.50 price target. To see the full list of analyst forecasts on BioHarvest Sciences stock, see the BHST Stock Forecast page.
Spark’s Take on BHST Stock
According to Spark, TipRanks’ AI Analyst, BHST is a Neutral.
BioHarvest Sciences faces significant financial challenges, with high leverage and negative equity impacting long-term sustainability. Technical indicators suggest bearish momentum, and valuation metrics are unattractive due to ongoing losses. Despite positive operational developments highlighted in the earnings call, the overall outlook remains cautious.
To see Spark’s full report on BHST stock, click here.
More about BioHarvest Sciences
BioHarvest Sciences Inc. operates in the biotechnology industry, focusing on developing and commercializing proprietary biofarming technology. The company’s primary products include innovative health and wellness solutions derived from plant-based biofarming processes, with a market focus on sustainable and efficient production of active plant ingredients.
Average Trading Volume: 77,663
Technical Sentiment Signal: Buy
Current Market Cap: $174.4M
For detailed information about BHST stock, go to TipRanks’ Stock Analysis page.